Division of Rheumatology
Brian D. Hanna
MD, FRCPC, MB
Education and Professional Standing
- MB, BCh, BAO, Queen’s University, Belfast, N. Ireland, 1967
- Medicine & Surgery Residency, University Affiliated Hospitals, Belfast, N.Ireland, 1968
- Medicine Resident, The American Hospital of Paris, France, 1968-69
- Internal Medicine Residency, University of Toronto, Toronto, 1969-72
- FRCP(C), Internal Medicine, 1972
- House Officer and Registrar, MRC Rheumatism Unit, Taplow, UK, 1974-75
- MRCP (UK), Internal Medicine, 1975
- Community Rheumatologist, Kitchener, 1975-present
Clinical Interests
Dr. Hanna is a clinician educator in The Division of Rheumatology. He teaches at an out-patient clinic, and consults one day a week, at Cambridge Memorial Hospital. He is consultant at Grand River and St Mary’s General Hospitals, Kitchener. He is the Director of the Rheumatology Day Hospital at St. Mary’s Hospital. His interest is in patient education, and in computer assisted record keeping. Dr. Hanna is involved in piloting the Ontario Biologic Research Initiative.
Selected Publications
- Tugwell P., Bombardier C., Buchanan W.W., Goldsmith C., Grace E., Hanna B.D., “The Mactar Patient Preference Disability Questionnaire – an Individualized Functional Priority Approach for Assessing Involvement in Physical Disability in Clinical Trials in Rheumatoid Arthritis”, Journal of Rheumatology 14:446-451. 1987
- Tugwell P., Bombardier C., Buchanan W.W., Grace E., Southwell D., Bianchi F., Hanna B.D., “ The Ability of the Mactar Disability Questionnaire to Detect Sensitivity to Change in Rheumatoid Arthritis”, Abstract presented to the American Federation for Clinical Research, April 29-May 2, 1983
- Grant E., Bellamy N., Grace E., Hanna B.D., Tugwell P., Buchanan W.W., “The Drug History: Fact or Fiction”, Annals of the Royal College of Physicians and Surgeons of Canada, Vol XVI (June 1983) 327
- Hanna B.D. and Gingrich N., “An Introduction to Rheumatoid Arthritis”, A Patient Education Monograph, circulated nationally, sponsored by Pfizer Pharmaceutical and the Canadian Arthritis Society, 1982.


